lunes, 11 de junio de 2012

Noninvasive Whole-Genome Sequencing of a Human Fetus

Noninvasive Whole-Genome Sequencing of a Human Fetus

Sci Transl Med
Vol. 4, Issue 137, p. 137ra76
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3004323
  • Research Article
Genomics

Noninvasive Whole-Genome Sequencing of a Human Fetus

  1. Jay Shendure1,*
+ Author Affiliations
  1. 1Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  2. 2Department of Biology, University of Bari, Bari 70126, Italy.
  3. 3Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195, USA.
  4. 4Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  5. 5Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.
  6. 6Global Alliance to Prevent Prematurity and Stillbirth, an initiative of Seattle Children’s, Seattle, WA 98101, USA.
  7. 7Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.
  8. 8Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.
  9. 9Treuman Katz Center for Pediatric Bioethics, Seattle Children’s Research Institute, Seattle, WA 98101, USA.
  10. 10Howard Hughes Medical Institute, Seattle, WA 98195, USA.
  1. *To whom correspondence should be addressed. E-mail: shendure@uw.edu (J.S.); kitz@uw.edu (J.O.K.)

Abstract

Analysis of cell-free fetal DNA in maternal plasma holds promise for the development of noninvasive prenatal genetic diagnostics. Previous studies have been restricted to detection of fetal trisomies, to specific paternally inherited mutations, or to genotyping common polymorphisms using material obtained invasively, for example, through chorionic villus sampling. Here, we combine genome sequencing of two parents, genome-wide maternal haplotyping, and deep sequencing of maternal plasma DNA to noninvasively determine the genome sequence of a human fetus at 18.5 weeks of gestation. Inheritance was predicted at 2.8 × 106 parental heterozygous sites with 98.1% accuracy. Furthermore, 39 of 44 de novo point mutations in the fetal genome were detected, albeit with limited specificity. Subsampling these data and analyzing a second family trio by the same approach indicate that parental haplotype blocks of ~300 kilo–base pairs combined with shallow sequencing of maternal plasma DNA is sufficient to substantially determine the inherited complement of a fetal genome. However, ultradeep sequencing of maternal plasma DNA is necessary for the practical detection of fetal de novo mutations genome-wide. Although technical and analytical challenges remain, we anticipate that noninvasive analysis of inherited variation and de novo mutations in fetal genomes will facilitate prenatal diagnosis of both recessive and dominant Mendelian disorders.
Citation: J. O. Kitzman, M. W. Snyder, M. Ventura, A. P. Lewis, R. Qiu, L. E. Simmons, H. S. Gammill, C. E. Rubens, D. A. Santillan, J. C. Murray, H. K. Tabor, M. J. Bamshad, E. E. Eichler, J. Shendure, Noninvasive Whole-Genome Sequencing of a Human Fetus. Sci. Transl. Med. 4, 137ra76 (2012).

No hay comentarios:

Publicar un comentario